Gujarat Alkalies and Chemicals Limited

NSE: GUJALKALI · Chemicals

₹610.20+0.12%06 Nov 2026

Ask the data

Instant answers about Gujarat Alkalies and Chemicals Limited — computed from its filings, no language model

Market cap₹4,481 cr

Current price₹610.20

High / Low₹802 / ₹414

P/E54.3

P/B0.85

Book value₹719.7

ROE1.6%

ROCE5.0%

Debt / equity0.12

Dividend yield2.60%

EPS (TTM)₹11.24

Face value₹10

Price & valuation

split & bonus adjusted · pick a metric and range

Annual performance

annual · ₹ crore · line = operating margin

showing latest 6 of 7 periods

	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Revenue	2,725	2,429	3,759	4,516	3,807	4,073	4,358
EBITDA	578	358	986	1,115	136	360	405
Operating margin	21.2%	14.7%	26.2%	24.7%	3.6%	8.8%	9.3%
Interest	14	15	6	19	45	51	63
Depreciation	162	174	198	276	377	392	414
Profit before tax	492	236	829	861	-196	10	44
Tax	159	69	267	285	-64	-6	23
Net profit	332	166	0	410	0	-65	0
EPS ₹	45.22	22.57	76.22	55.78	-32.25	-8.87	-0.33
Operating cash flow	—	—	737	1,126	171	462	430
Capex	—	—	909	683	231	325	258
Dividend paid	—	—	59	74	173	102	116
Total assets	—	—	—	8,335	8,023	7,987	7,533
Equity	—	—	—	6,139	6,076	5,670	5,191

Quarterly performance

last 30 quarters · ₹ crore

showing latest 8 of 30 periods

	JUN '19	SEP '19	DEC '19	MAR '20	JUN '20	SEP '20	DEC '20	MAR '21	JUN '21	SEP '21	DEC '21	MAR '22	JUN '22	SEP '22	DEC '22	MAR '23	JUN '23	SEP '23	DEC '23	MAR '24	JUN '24	SEP '24	DEC '24	MAR '25	JUN '25	SEP '25	DEC '25	MAR '26	JUN '26	SEP '26
Revenue	749	699	656	622	470	638	650	671	716	826	1,075	1,141	1,128	1,127	1,123	1,138	913	971	921	1,002	977	991	1,029	1,075	1,105	1,083	1,044	1,125	1,245	1,358
Operating profit	252	151	94	80	78	105	79	96	127	142	366	350	382	226	264	243	55	45	7	29	74	75	98	114	117	74	105	110	222	170
Operating margin	33.7%	21.7%	14.4%	12.8%	16.7%	16.4%	12.1%	14.4%	17.7%	17.2%	34.1%	30.7%	33.8%	20.0%	23.5%	21.3%	6.0%	4.7%	0.8%	2.9%	7.5%	7.6%	9.5%	10.6%	10.6%	6.8%	10.0%	9.8%	17.8%	12.5%
Other income	17	37	18	18	13	28	17	9	15	22	3	7	6	22	6	8	12	71	5	3	3	49	15	24	8	59	30	18	8	52
Interest	4	3	4	3	3	2	2	9	2	1	1	1	2	3	8	8	10	11	11	12	11	11	10	18	14	16	18	15	16	15
Depreciation	37	38	39	48	42	43	45	44	47	49	50	52	50	60	79	88	89	95	96	97	97	100	98	97	102	104	104	104	103	104
Profit before tax	228	146	70	47	46	88	50	52	93	114	318	304	336	186	184	155	-33	10	-95	-77	-30	13	4	23	10	13	13	8	110	102
Tax	69	44	10	36	14	21	16	18	30	39	116	82	114	58	70	44	0	-0	-7	-56	-6	2	-4	1	2	-3	24	0	57	23
Net profit	0	102	60	11	32	66	0	35	63	75	201	0	191	0	0	71	-57	-18	-115	0	-45	-18	-11	9	0	16	0	0	0	83
EPS ₹	21.62	13.93	8.11	1.55	4.33	8.99	4.53	4.72	8.60	10.15	27.42	30.05	25.99	8.24	11.87	9.68	-7.78	-2.50	-15.68	-6.29	-6.06	-2.48	-1.53	1.20	-1.88	2.23	-2.72	2.04	7.49	11.24
Revenue YoY	—	—	—	—	-37.3%	-8.7%	-0.8%	8.0%	52.6%	29.4%	65.3%	70.0%	57.5%	36.5%	4.4%	-0.3%	-19.1%	-13.8%	-18.0%	-12.0%	7.1%	2.0%	11.8%	7.4%	13.1%	9.3%	1.5%	4.6%	12.6%	25.3%
Profit YoY	—	—	—	—	—	-35.4%	-100.0%	204.0%	98.4%	12.9%	—	-100.0%	202.4%	-100.0%	-100.0%	—	-129.9%	—	—	-100.0%	—	—	—	—	—	—	—	-100.0%	—	405.3%

Earlier results (standalone, Sep '07 – Mar '19)

₹ crore · from BSE, before the NSE XBRL filings begin

Gujarat Alkalies and Chemicals Limited reports consolidated figures above. Quarterly consolidated results only became mandatory in India in 2019, so the earlier history available is the standalone company only (excluding subsidiaries). It is shown separately so the two bases are never mixed.

Full years

showing latest 8 of 11 periods

	FY09†	FY10†	FY11†	FY12†	FY13†	FY14†	FY15†	FY16†	FY17†	FY18†	FY19†
Revenue	1,413	1,316	1,435	1,712	1,815	1,896	1,948	1,966	2,243	2,514	3,161
Operating profit	385	266	269	386	486	373	274	334	450	787	1,115
Operating margin	27.3%	20.2%	18.7%	22.6%	26.8%	19.7%	14.1%	17.0%	20.0%	31.3%	35.3%
Other income	17	24	11	11	19	30	49	46	56	106	61
Interest	25	17	20	19	8	6	9	8	13	15	21
Depreciation	109	122	133	139	142	151	98	107	111	127	140
Profit before tax	261	146	127	223	337	247	215	265	382	750	1,015
Tax	69	-26	13	70	101	62	-12	43	74	215	325
Net profit	192	172	114	154	235	185	228	222	308	535	690

Quarters

showing latest 8 of 47 periods

	SEP '07†	DEC '07†	MAR '08†	JUN '08†	SEP '08†	DEC '08†	MAR '09†	JUN '09†	SEP '09†	DEC '09†	MAR '10†	JUN '10†	SEP '10†	DEC '10†	MAR '11†	JUN '11†	SEP '11†	DEC '11†	MAR '12†	JUN '12†	SEP '12†	DEC '12†	MAR '13†	JUN '13†	SEP '13†	DEC '13†	MAR '14†	JUN '14†	SEP '14†	DEC '14†	MAR '15†	JUN '15†	SEP '15†	DEC '15†	MAR '16†	JUN '16†	SEP '16†	DEC '16†	MAR '17†	JUN '17†	SEP '17†	DEC '17†	MAR '18†	JUN '18†	SEP '18†	DEC '18†	MAR '19†
Revenue	295	284	306	344	392	330	347	335	337	321	322	330	353	345	408	421	420	443	427	441	482	420	472	415	467	510	505	497	498	457	496	475	478	467	546	523	587	542	590	604	595	618	697	753	772	816	821
Operating profit	95	91	72	101	138	78	68	90	67	55	54	59	52	56	102	118	84	76	108	118	113	101	154	87	81	86	119	94	67	60	52	78	75	48	133	134	122	85	108	154	161	179	293	287	278	276	274
Operating margin	32.1%	32.0%	23.7%	29.4%	35.2%	23.6%	19.6%	26.9%	19.8%	17.2%	16.7%	17.8%	14.8%	16.1%	25.0%	28.2%	19.9%	17.1%	25.3%	26.7%	23.5%	24.0%	32.7%	21.0%	17.4%	16.9%	23.6%	19.0%	13.5%	13.0%	10.6%	16.3%	15.6%	10.4%	24.4%	25.6%	20.8%	15.7%	18.4%	25.5%	27.1%	29.0%	42.0%	38.2%	36.0%	33.8%	33.3%
Other income	26	17	10	8	7	1	2	1	6	2	15	1	8	2	1	0	8	1	2	1	11	4	3	5	13	8	5	6	21	7	16	6	19	9	12	7	22	10	16	8	28	10	60	9	14	24	15
Interest	7	6	5	7	6	6	6	6	4	4	3	4	5	5	5	6	5	5	4	3	3	2	1	2	2	2	1	3	3	2	1	2	2	2	2	2	2	5	3	4	4	4	4	4	4	9	4
Depreciation	25	25	25	26	27	27	29	30	31	31	30	33	33	34	33	33	35	36	35	35	35	37	36	37	39	38	37	23	25	25	25	26	27	27	28	27	28	27	28	30	37	31	30	33	36	37	35
Profit before tax	90	77	52	71	112	45	33	50	38	23	36	22	22	18	65	64	52	36	71	81	86	48	121	54	53	54	86	74	60	39	43	57	65	29	115	112	114	63	92	128	148	154	320	259	253	254	249
Tax	7	5	33	17	29	13	11	12	9	3	-50	3	2	-1	9	18	15	10	27	26	20	15	41	16	5	19	21	17	11	13	-54	13	18	14	-0	26	27	16	5	33	42	42	98	76	78	92	79
Net profit	83	72	18	54	84	32	22	38	29	19	86	19	20	19	56	46	37	26	44	55	66	33	81	37	48	35	65	57	49	26	96	44	48	15	115	86	87	47	87	95	106	112	221	183	174	162	170
EPS ₹	11.32	9.82	2.50	7.42	11.41	4.42	2.94	5.16	3.95	2.63	11.66	2.59	2.74	2.61	7.62	6.32	5.05	3.53	6.02	7.53	8.99	4.54	10.99	5.08	6.51	4.80	8.81	7.75	6.63	3.53	13.12	5.99	6.50	2.07	15.62	11.75	11.90	6.44	11.86	12.99	14.48	15.28	30.10	24.94	23.74	22.10	23.13
Revenue YoY	—	—	—	—	32.8%	16.4%	13.4%	-2.5%	-14.1%	-2.7%	-7.2%	-1.6%	4.6%	7.5%	26.5%	27.5%	19.2%	28.4%	4.9%	4.9%	14.6%	-5.3%	10.5%	-6.0%	-3.1%	21.5%	6.9%	19.9%	6.8%	-10.4%	-1.8%	-4.4%	-4.0%	2.1%	10.1%	10.1%	22.8%	16.1%	8.0%	15.4%	1.3%	13.9%	18.3%	24.7%	29.7%	32.2%	17.7%
Profit YoY	—	—	—	—	0.8%	-55.0%	17.6%	-30.4%	-65.4%	-40.5%	296.8%	-49.9%	-30.6%	-0.6%	-34.6%	144.1%	84.2%	35.2%	-21.0%	19.1%	78.1%	28.5%	82.6%	-32.5%	-27.6%	5.6%	-19.8%	52.7%	1.9%	-26.4%	48.8%	-22.8%	-1.9%	-41.3%	19.1%	96.1%	83.0%	211.1%	-24.1%	10.5%	21.7%	137.1%	153.8%	92.1%	63.9%	44.6%	-23.2%

Returns & margins

trailing-twelve-month, per quarter

showing latest 8 of 27 periods

	MAR '20	JUN '20	SEP '20	DEC '20	MAR '21	JUN '21	SEP '21	DEC '21	MAR '22	JUN '22	SEP '22	DEC '22	MAR '23	JUN '23	SEP '23	DEC '23	MAR '24	JUN '24	SEP '24	DEC '24	MAR '25	JUN '25	SEP '25	DEC '25	MAR '26	JUN '26	SEP '26
ROE	—	—	—	—	—	—	—	—	—	—	6.4%	3.1%	4.3%	0.2%	-0.1%	-2.0%	-3.1%	-2.9%	-2.9%	-1.2%	-1.1%	-0.4%	0.3%	0.5%	0.3%	0.3%	1.6%
ROCE	—	—	—	—	—	—	—	—	—	—	17.2%	15.3%	13.1%	7.7%	5.4%	1.2%	-2.3%	-2.2%	-2.1%	-0.7%	1.0%	1.7%	1.7%	2.0%	1.9%	3.7%	5.0%
Net margin	6.4%	8.4%	7.1%	4.6%	5.5%	6.1%	6.0%	11.4%	9.0%	11.2%	8.8%	4.2%	5.8%	0.3%	-0.1%	-3.0%	-5.0%	-4.6%	-4.6%	-1.8%	-1.6%	-0.5%	0.3%	0.6%	0.4%	0.4%	1.7%
EBITDA margin	21.2%	16.5%	15.0%	14.4%	14.7%	15.2%	15.5%	22.3%	26.2%	29.8%	29.6%	27.0%	24.7%	18.3%	14.6%	8.9%	3.6%	4.0%	4.7%	6.9%	8.8%	9.6%	9.4%	9.5%	9.3%	11.3%	12.7%
Debt / equity	—	—	—	—	—	—	—	—	—	—	0.10	0.10	0.10	0.10	0.09	0.09	0.09	0.09	0.10	0.10	0.10	0.10	0.11	0.11	0.11	0.11	0.12
Interest coverage	36.02	24.55	22.47	24.96	16.25	20.36	22.79	43.32	135.74	196.94	170.91	79.09	45.25	18.32	9.64	1.92	-3.39	-3.29	-3.21	-1.04	1.19	1.93	1.86	1.88	1.69	3.19	4.56
Asset turnover	—	—	—	—	—	—	—	—	—	—	0.54	0.54	0.54	0.52	0.50	0.48	0.47	0.48	0.46	0.48	0.51	0.53	0.52	0.52	0.58	0.60	0.59

Balance sheet

equity vs borrowings over time · ₹ crore

showing latest 6 of 9 periods

	SEP '22	MAR '23	SEP '23	MAR '24	SEP '24	MAR '25	SEP '25	MAR '26	SEP '26
Share capital	73	73	73	73	73	73	73	73	73
Other equity / reserves	6,018	6,066	5,926	6,002	6,112	5,596	5,497	5,117	5,212
Total equity	6,091	6,139	6,000	6,076	6,186	5,670	5,570	5,191	5,286
Borrowings	603	596	534	543	602	552	628	568	642
Current liabilities	865	840	933	745	1,022	933	1,252	993	1,314
Non-current liabilities	1,373	1,356	1,294	1,203	1,206	1,384	1,387	1,348	1,440
Total assets	8,329	8,335	8,227	8,023	8,413	7,987	8,209	7,533	8,040
Property, plant & equipment	4,004	4,246	4,695	4,615	4,490	4,583	4,521	4,343	4,194
Capital work-in-progress	766	544	39	95	157	79	37	122	234
Investments	2,019	1,831	1,888	2,093	2,377	1,976	2,044	1,633	1,783
Inventories	391	461	525	407	402	486	454	450	585
Receivables	300	285	137	178	254	263	295	407	576
Cash & equivalents	367	456	153	155	170	126	251	157	105

Cash flow

annual · ₹ crore · line = free cash flow

	FY22	FY23	FY24	FY25	FY26
Cash from operations	737	1,126	171	462	430
Cash from investing	-808	-827	-195	-345	-251
Cash from financing	12	-140	-277	-145	-150
Capex	909	683	231	325	258
Free cash flow	-172	443	-60	137	171
Dividends paid	59	74	173	102	116

Where the assets sit

Sep '26 · ₹ crore

Fixed assets (PPE)

₹4,194 cr52%

CWIP

₹234 cr3%

Investments

₹1,783 cr22%

Inventories

₹585 cr7%

Receivables

₹576 cr7%

Cash & equivalents

₹105 cr1%

Other assets

₹563 cr7%

Peer comparison

largest in Chemicals · this company in bold

Company	Market cap ₹cr	Price	P/E	P/B	ROE
Solar Industries India Ltd.	1,68,402	18,608.00	74.4	21.95	29.5%
Pidilite Industries Ltd.	1,60,821	1,579.00	59.9	14.34	23.9%
SRF Ltd.	72,931	2,460.40	143.2	4.77	3.3%
Linde India Ltd.	58,496	6,859.00	755.3	13.33	1.8%
Coromandel International Ltd.	53,808	1,824.00	31.8	428.48	1349.1%
Gujarat Fluorochemicals Ltd.	51,320	4,665.50	75.6	6.12	8.1%
Fertilisers and Chemicals Travancore Ltd.	48,546	750.25	—	35.30	-3.1%
Navin Fluorine International Ltd.	46,221	9,010.00	50.8	10.36	20.4%
UPL Ltd.	45,199	534.90	23.9	1.30	5.4%
Himadri Speciality Chemical Ltd.	28,669	568.15	33.5	5.58	16.6%
Gujarat Alkalies and Chemicals Limited	4,481	610.20	54.3	0.85	1.6%

StoxGud checklist: Neutral setup · 6/10

Price above 50-day average
Price above 200-day average
50-day average above 200-day (uptrend)
RSI in healthy 40–70 zone
Positive 1-year return
Return on equity above 15%
Debt to equity below 1
Revenue growing year on year
Net profit margin above 10%
P/E below industry median

A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.

Returns & technicals

1 month-0.9%

6 months-22.8%

1 year+6.4%

3Y CAGR-5.8%

5Y CAGR-4.2%

10Y CAGR+4.4%

50-day avg₹629.09

200-day avg₹610.07

RSI (14)58

FAQs

What is the share price of Gujarat Alkalies and Chemicals Limited?

Gujarat Alkalies and Chemicals Limited (GUJALKALI) closed at ₹610.20 on NSE on 06 Nov 2026.

What is the market cap of Gujarat Alkalies and Chemicals Limited?

₹4,481 crore at the latest close.

What is the P/E ratio of Gujarat Alkalies and Chemicals Limited?

54.3, on trailing-twelve-month earnings from its filings.

How fast is Gujarat Alkalies and Chemicals Limited growing?

Gujarat Alkalies and Chemicals Limited: revenue has compounded at -1.2% a year over three years. Latest-quarter revenue is up 25.3% year on year, profit up 405.3%.

How profitable is Gujarat Alkalies and Chemicals Limited?

On a trailing-twelve-month basis return on equity is 1.6%, return on capital employed 5.0%, operating margin 12.7%, net margin 1.7%.

How much debt does Gujarat Alkalies and Chemicals Limited have?

Gujarat Alkalies and Chemicals Limited is lightly geared: debt to equity is 0.12 with borrowings of ₹642 cr against cash of ₹105 cr (balance sheet of 2026-09-30). Operating profit covers interest 4.6 times.

Financials parsed from Gujarat Alkalies and Chemicals Limited's own XBRL filings to NSE (consolidated), ₹ crore unless marked. Quarterly from JUN '19, annual from FY20, balance sheet from Sep '22. * = derived (full year or half year minus earlier quarters). Information only, not investment advice.